Canada markets closed

Shandong Xinhua Pharmaceutical Company Limited (XIN.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.6750-0.0050 (-0.74%)
At close: 08:05AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 1.15B
Enterprise Value 1.20B
Trailing P/E 7.53
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.46
Price/Book (mrq)0.77
Enterprise Value/Revenue 1.19
Enterprise Value/EBITDA 17.05

Trading Information

Stock Price History

Beta (5Y Monthly) -0.01
52-Week Change 3-4.90%
S&P500 52-Week Change 326.49%
52 Week High 30.7700
52 Week Low 30.5500
50-Day Moving Average 30.6256
200-Day Moving Average 30.6310

Share Statistics

Avg Vol (3 month) 398
Avg Vol (10 day) 3N/A
Shares Outstanding 5195M
Implied Shares Outstanding 61.7B
Float 8407.19M
% Held by Insiders 110.68%
% Held by Institutions 11.57%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.03
Forward Annual Dividend Yield 43.73%
Trailing Annual Dividend Rate 30.25
Trailing Annual Dividend Yield 336.76%
5 Year Average Dividend Yield 43.46
Payout Ratio 428.53%
Dividend Date 3N/A
Ex-Dividend Date 4Jul 07, 2023
Last Split Factor 213:10
Last Split Date 3Jul 06, 2018

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 6.13%
Operating Margin (ttm)6.93%

Management Effectiveness

Return on Assets (ttm)3.67%
Return on Equity (ttm)10.43%

Income Statement

Revenue (ttm)7.94B
Revenue Per Share (ttm)11.70
Quarterly Revenue Growth (yoy)-6.30%
Gross Profit (ttm)N/A
EBITDA 1B
Net Income Avi to Common (ttm)486.79M
Diluted EPS (ttm)0.0900
Quarterly Earnings Growth (yoy)-6.40%

Balance Sheet

Total Cash (mrq)922.05M
Total Cash Per Share (mrq)1.35
Total Debt (mrq)1.32B
Total Debt/Equity (mrq)26.36%
Current Ratio (mrq)1.42
Book Value Per Share (mrq)6.98

Cash Flow Statement

Operating Cash Flow (ttm)487.09M
Levered Free Cash Flow (ttm)320.7M